Financials data is unavailable for this security.
View more
Year on year Bio-Techne Corp grew net income 4.86% 272.05m to 285.26m despite revenues that were unchanged.
| Gross margin | 66.80% |
|---|---|
| Net profit margin | 17.59% |
| Operating margin | 22.13% |
| Return on assets | 7.63% |
|---|---|
| Return on equity | 10.40% |
| Return on investment | 8.07% |
More ▼
Cash flow in USDView more
In 2023, Bio-Techne Corp did not generate a significant amount of cash. However, the company earned 254.39m from its operations for a Cash Flow Margin of 22.38%. In addition the company generated 22.62m cash from financing while 265.65m was spent on investing.
| Cash flow per share | 1.95 |
|---|---|
| Price/Cash flow per share | 39.83 |
| Book value per share | 12.79 |
|---|---|
| Tangible book value per share | 3.28 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.08 |
|---|---|
| Quick ratio | 2.88 |
| Total debt/total equity | 0.1931 |
|---|---|
| Total debt/total capital | 0.1619 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 6.34%. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is the above the industry average.
| Div yield(5 year avg) | 0.43% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | 24.83% |
| EPS growth(5 years) | 23.61 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -24.76 |
More ▼
